These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Gum RJ; Gaede LL; Koterski SL; Heindel M; Clampit JE; Zinker BA; Trevillyan JM; Ulrich RG; Jirousek MR; Rondinone CM Diabetes; 2003 Jan; 52(1):21-8. PubMed ID: 12502489 [TBL] [Abstract][Full Text] [Related]
5. In vivo antisense activity of ENA oligonucleotides targeting PTP1B mRNA in comparison of that of 2'-MOE-modified oligonucleotides. Koizumi M; Takagi-Sato M; Okuyama R; Araki K; Sun W; Nakai D Nucleic Acids Symp Ser (Oxf); 2007; (51):111-2. PubMed ID: 18029611 [TBL] [Abstract][Full Text] [Related]
6. Antisense protein tyrosine phosphatase 1B reverses activation of p38 mitogen-activated protein kinase in liver of ob/ob mice. Gum RJ; Gaede LL; Heindel MA; Waring JF; Trevillyan JM; Zinker BA; Stark ME; Wilcox D; Jirousek MR; Rondinone CM; Ulrich RG Mol Endocrinol; 2003 Jun; 17(6):1131-43. PubMed ID: 12649327 [TBL] [Abstract][Full Text] [Related]
7. Reduction of PTP1B induces differential expression of PI3-kinase (p85alpha) isoforms. Rondinone CM; Clampit J; Gum RJ; Zinker BA; Jirousek MR; Trevillyan JM Biochem Biophys Res Commun; 2004 Oct; 323(2):652-9. PubMed ID: 15369800 [TBL] [Abstract][Full Text] [Related]
8. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance. Goldstein BJ Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):265-75. PubMed ID: 12477292 [TBL] [Abstract][Full Text] [Related]
9. Direct comparison of in vivo antisense activity of ENA oligonucleotides targeting PTP1B mRNA with that of 2'-O-(2-methoxy)ethyl-modified oligonucleotides. Koizumi M; Takagi-Sato M; Okuyama R; Araki K; Sun W; Nakai D; Tsutsumi S; Kawai K Oligonucleotides; 2006; 16(3):253-62. PubMed ID: 16978088 [TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes. Liu G; Trevillyan JM Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961 [TBL] [Abstract][Full Text] [Related]
11. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. Zabolotny JM; Haj FG; Kim YB; Kim HJ; Shulman GI; Kim JK; Neel BG; Kahn BB J Biol Chem; 2004 Jun; 279(23):24844-51. PubMed ID: 15031294 [TBL] [Abstract][Full Text] [Related]
12. Leptin increases hepatic insulin sensitivity and protein tyrosine phosphatase 1B expression. Lam NT; Lewis JT; Cheung AT; Luk CT; Tse J; Wang J; Bryer-Ash M; Kolls JK; Kieffer TJ Mol Endocrinol; 2004 Jun; 18(6):1333-45. PubMed ID: 14976221 [TBL] [Abstract][Full Text] [Related]
13. PTPIP51 interaction with PTP1B and 14-3-3β in adipose tissue of insulin-resistant mice. Bobrich M; Brobeil A; Mooren FC; Krüger K; Steger K; Tag C; Wimmer M Int J Obes (Lond); 2011 Nov; 35(11):1385-94. PubMed ID: 21266951 [TBL] [Abstract][Full Text] [Related]
14. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes. Gonzalez-Rodriguez A; Clampit JE; Escribano O; Benito M; Rondinone CM; Valverde AM Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137 [TBL] [Abstract][Full Text] [Related]
15. Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice. Pandey SK; Yu XX; Watts LM; Michael MD; Sloop KW; Rivard AR; Leedom TA; Manchem VP; Samadzadeh L; McKay RA; Monia BP; Bhanot S J Biol Chem; 2007 May; 282(19):14291-9. PubMed ID: 17353188 [TBL] [Abstract][Full Text] [Related]
16. Reduction of protein-tyrosine phosphatase-1B increases insulin signaling in FAO hepatoma cells. Clampit JE; Meuth JL; Smith HT; Reilly RM; Jirousek MR; Trevillyan JM; Rondinone CM Biochem Biophys Res Commun; 2003 Jan; 300(2):261-7. PubMed ID: 12504077 [TBL] [Abstract][Full Text] [Related]
17. Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance. Xue B; Kim YB; Lee A; Toschi E; Bonner-Weir S; Kahn CR; Neel BG; Kahn BB J Biol Chem; 2007 Aug; 282(33):23829-40. PubMed ID: 17545163 [TBL] [Abstract][Full Text] [Related]
18. Knocking down amygdalar PTP1B in diet-induced obese rats improves insulin signaling/action, decreases adiposity and may alter anxiety behavior. Mendes NF; Castro G; Guadagnini D; Tobar N; Cognuck SQ; Elias LL; Boer PA; Prada PO Metabolism; 2017 May; 70():1-11. PubMed ID: 28403933 [TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances. Harley EA; Levens N Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209 [TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatase 1B inhibition: opportunities and challenges. Liu G Curr Med Chem; 2003 Aug; 10(15):1407-21. PubMed ID: 12871138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]